Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
From MaRDI portal
Publication:121634
DOI10.1002/PST.1891WikidataQ90971711 ScholiaQ90971711MaRDI QIDQ121634
Andrew G. Chapple, Peter F Thall
Publication date: 15 August 2018
Published in: Pharmaceutical Statistics (Search for Journal in Brave)
Related Items (1)
This page was built for publication: Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination